HMH
INSIDER BUYHMH Holding Inc.
Research: Finviz ↗·Perplexity ↗
No convergence signal this quarter — shown because tracked funds have filed 13D/G on this stock.
News Summary
NegativeHMH reported Q3 2026 revenue down 21% YoY to $171.1M with net income declining 69%, driven primarily by $17M in Middle East conflict-related delays and equipment order backlog reductions. Management cut full-year 2026 adjusted EBITDA guidance to $135–140M, prompting downgrades from JPMorgan (Overweight to Neutral) and Zacks (Strong Buy to Hold), though the company projects 10–25% floater activity growth in 2027 with 85% backed by firm backlog.
Red flags
- •Revenue declined 21% YoY; product revenue collapsed 69% due to equipment order backlog and project delays
- •Full-year 2026 adjusted EBITDA guidance cut, with Q4 expected flat-to-slightly-below Q3 levels
- •Middle East conflict impact of $17M in revenue and $8M in adjusted EBITDA for nine months YTD
- •Net income fell 69% ($5.0M vs. $16.2M) despite modest EBITDA margin expansion, indicating operational stress
- •Two major analyst downgrades (JPMorgan to Neutral, Zacks to Hold) within one week of earnings
- •Recent IPO (April 2026) stock has faced sustained pressure from guidance cut and execution challenges
Insider Activity
Fund 13D/13G Filings (4)
Tracked funds' beneficial-ownership filings on this stock — disclosed within days of a position change, fresher than the quarterly 13F. Since Filing compares the stock to SPY from the filing date (shown for filings within the last 90 days).
| Fund | Form | ∆ Shares | % of Class | Since Filing | Filed | Src |
|---|---|---|---|---|---|---|
| Citadel Advisors | SC 13G/A | −629K | 0.3% | -0.1% vs SPY -3.4% abs | 2026-11-16 | ↗ |
| Point72 | SC 13G/A | −575K | 0.0% | -36.5% vs SPY -38.7% abs | 2026-08-14 | ↗ |
| Citadel Advisors | SC 13G | NEW | 6.3% | — | 2026-04-09 | ↗ |
| Point72 | SC 13G | NEW | 5.5% | — | 2026-04-06 | ↗ |